Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Dermatol ; 135(5): 540-4, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10328194

RESUMO

BACKGROUND: Dihydroxyacetone (DHA), a colorless sugar in "sunless" tanning lotions, binds to stratum corneum to form a UV-A-protective brown pigment. Bound DHA polymer is shed faster from hyperproliferative skin sites such as psoriatic plaques. We tested the hypothesis that selective shedding of DHA pigment during psoralen-UV-A (PUVA) treatment of psoriasis may allow higher UV-A doses, thus accelerating clearing while protecting uninvolved skin. Concurrent use of lactic acid was investigated as an aid in removing scale and residual DHA from psoriatic plaques. OBSERVATIONS: Thirty psoriatic patients with more than 20% body surface area involvement were recruited. The 6 PUVA study groups were (1) standard American style, (2) American style plus lactic acid, (3) DHA-PUVA or "topical ultraviolet-resisting barrier to optiimize PUVA" (Turbo-PUVA), (4) Turbo-PUVA with lactic acid, (5) European style, and (6) European style plus DHA. Combinations of lactic acid and European-style treatment were not studied. Each subject received up to 30 oral PUVA treatments twice weekly 3 days apart. The DHA-PUVA groups used 15% DHA lotion twice weekly. Lactic acid groups used 7% lotion daily except on treatment days. Psoriasis area and severity index scores were recorded weekly. Turbo-PUVA allowed higher UV-A exposures with minimal burns, showed faster clearing, and required fewer treatments for 90% clearing (P<.001). CONCLUSIONS: Protection of uninvolved skin by DHA during PUVA treatment allows higher UV-A exposures to be tolerated, demonstrates faster clearing, and requires fewer treatments to clear psoriasis. By reducing the total body dose received, Turbo-PUVA may also reduce long-term risks.


Assuntos
Di-Hidroxiacetona/uso terapêutico , Terapia PUVA , Psoríase/tratamento farmacológico , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto
2.
Br J Dermatol ; 135(4): 545-9, 1996 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8915143

RESUMO

Calcipotriol, a vitamin D analogue utilized for psoriasis, has irritation as its most frequent reported adverse event. However, studies on its irritant properties in humans have produced conflicting data. This study evaluates the effect of calcipotriol on stratum corneum barrier function, hydration and cell turnover in healthy volunteers, compared with sodium lauryl sulphate (SLS) as a model irritant. Calcipotriol 0.005% ointment and 1% aqueous SLS solution were applied for 60 min once daily for 2 weeks (5 consecutive days weekly) on untreated and on dansyl-chloride-labelled skin. Irritant responses were documented by visual scoring and by measurement of the transepidermal water loss (TEWL) and stratum corneum hydration (electrical capacitance), until day 18. Stratum corneum turnover time (SCTT) was the time in days between staining (day 0) and the disappearance of dansyl fluorescence. SLS caused more erythema, scaling, and a significant TEWL increase for 18 days. In contrast, calcipotriol induced erythema, and slightly but significantly increased TEWL on day 11 only, as compared with the vehicle control (P < 0.05). SLS, but not calcipotriol, caused skin dryness from day 4 to day 18. The shortest SCTT was obtained at SLS-exposed sites (11.2 +/- 0.7 days: mean +/- SD). Calcipotriol significantly shortened SCTT (16.3 +/- 1.1 days) when compared with its vehicle. Compared with the skin irritation induced by SLS, under these test conditions, calcipotriol is a far weaker irritant on normal human skin. In addition, calcipotriol accelerates stratum corneum turnover to a significantly greater extent than its vehicle.


Assuntos
Calcitriol/análogos & derivados , Fármacos Dermatológicos/farmacologia , Epiderme/efeitos dos fármacos , Resposta Galvânica da Pele/efeitos dos fármacos , Perda Insensível de Água/efeitos dos fármacos , Adulto , Calcitriol/farmacologia , Calcitriol/toxicidade , Divisão Celular/efeitos dos fármacos , Fármacos Dermatológicos/toxicidade , Toxidermias/etiologia , Eritema/induzido quimicamente , Eritema/patologia , Eritema/fisiopatologia , Feminino , Humanos , Masculino , Dodecilsulfato de Sódio/farmacologia
3.
Br J Dermatol ; 135(3): 428-32, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8949438

RESUMO

Recent in vivo investigations have shown that pretreatment with topical all-trans retinoic acid (RA) may diminish the skin response to sodium lauryl sulphate (SLS). This study evaluated the permeation of SLS through human skin after pretreatment with RA, and vice versa, by in vitro methods. The permeability coefficient of SLS (3.24 +/- 0.21 x 10(3) cm/h) and the 24-h cumulative amount of SLS (3.41 +/- 0.6% of dose applied) permeating RA-pretreated skin did not differ significantly from those across untreated skin (control) (P > 0.05). In contrast, the permeability coefficient of RA (0.23 +/- 0.05 x 10(3) cm/h) and its 24-h cumulative amount (0.37 +/- 0.05% of dose applied) penetrating SLS-pretreated skin were significantly greater than those permeating untreated skin (P < 0.05). Thus, an increase in RA penetration was induced by SLS pretreatment; however, pretreating the skin with RA did not inhibit the percutaneous permeation of SLS. Based on previous in vivo findings where RA reduced skin reactions to SLS, one would speculate that RA pretreatment may decrease SLS penetration. However, these penetration data do not necessarily uphold this presumption. Perhaps, other interactions between the substances and the skin, e.g. at cellular levels, may be responsible for the differing skin responses.


Assuntos
Ceratolíticos/farmacologia , Absorção Cutânea/efeitos dos fármacos , Dodecilsulfato de Sódio/farmacologia , Tensoativos/farmacologia , Tretinoína/farmacologia , Adulto , Interações Medicamentosas , Humanos , Técnicas In Vitro , Ceratolíticos/farmacocinética , Masculino , Permeabilidade/efeitos dos fármacos , Pele/metabolismo , Dodecilsulfato de Sódio/farmacocinética , Tensoativos/farmacocinética , Tretinoína/farmacocinética
4.
Acta Derm Venereol ; 75(6): 455-8, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8651024

RESUMO

The effects of topical glycolic acid and all-trans retinoic acid on stratum corneum barrier function and hydration of human skin were investigated in 6 healthy volunteers utilizing non-invasive techniques. In addition, changes in stratum corneum turnover time induced by the substances were examined using the dansyl chloride fluorescence test. Twelve percent glycolic acid in water and 0.1% retinoic acid in ethanol, respectively, were applied for 60 min once daily, over a period of 2 weeks (5 consecutive days weekly) on dansyl chloride-labelled skin and on untreated skin. During a 10-day application period, both glycolic acid and retinoic acid similarly induced a significant increase in TEWL. However, after discontinuing treatment, TEWL in retinoic acid-exposed skin remained increased. Glycolic acid significantly reduced stratum corneum hydration from day 11 to day 18 (p < 0.05), while retinoic acid induced skin dryness after 9 days of treatment, which persisted until day 18 (p < 0.005). Whereas glycolic acid rapidly induced an intense erythema implying a direct non-specific inflammatory response, the retinoic acid-exposed skin gradually developed erythema. Retinoic acid caused scaling to a greater extent than did glycolic acid, even after treatment cessation. Both glycolic acid and retinoic acid significantly decreased stratum corneum turnover time and stratum corneum turnover time50 (the time in days from labelling until approximately 50% of fluorescence disappeared), compared with the vehicle controls. However, glycolic acid shortened stratum corneum turnover time (12.8 +/- 0.9 days) as well as stratum corneum turnover time50 (7.3 +/- 0.7 d) significantly more than did retinoic acid (15.8 +/- 0.7 d and 9 +/- 0.8 d, respectively). While ethanol (vehicle of retinoic acid) slightly but significantly decreased stratum corneum turnover time (p < 0.05), water (vehicle of glycolic acid) did not. This study showed that both glycolic acid and retinoic acid induced certain functional changes in stratum corneum, mirroring their irritation potential. However, changes at retinoic acid-exposed sites appeared longer-lasting, implying a distinct mode of action. An increase in stratum corneum turnover induced by the substances may be, in part, linked with their irritation properties.


Assuntos
Epiderme/efeitos dos fármacos , Epiderme/fisiologia , Glicolatos/farmacologia , Ceratolíticos/farmacologia , Tretinoína/farmacologia , Adulto , Água Corporal/metabolismo , Epiderme/metabolismo , Feminino , Humanos , Irritantes/farmacologia , Masculino , Perda Insensível de Água
5.
Contact Dermatitis ; 33(5): 289-98, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8565482

RESUMO

This article reviews the effect of age and sex on the induction and elicitation of allergic contact dermatitis (ACD). We found that the incidence of ACD in childhood is lower than in adults; this may be explained by less exposure to allergens, lack of immune response and limited patch test studies in this age group. In the elderly, there is an age-dependent decrease in the incidence of ACD, with decreased sensitization to new allergens and waning responses in previously sensitized subjects. There is extensive controversy about the effect of sex differences in ACD. The induction phases of ACD in both sexes are different due to differences in exposure to the allergens from occupations, habits and cultures. Differences in elicitation phases of ACD in both sexes are not confirmed. Women tend to have a higher incidence of ACD and higher immunologic response to exposure allergens than men. Thus we can only imprecisely define the effect of age and sex on the induction and elicitation of ACD. Further prospective studies should be done to answer these questions.


Assuntos
Envelhecimento , Dermatite Alérgica de Contato/etiologia , Caracteres Sexuais , Adolescente , Adulto , Idoso , Alérgenos/efeitos adversos , Alérgenos/imunologia , Criança , Dermatite Alérgica de Contato/imunologia , Exposição Ambiental , Feminino , Humanos , Imunização , Incidência , Masculino , Pessoa de Meia-Idade
8.
Mycoses ; 33(11-12): 513-7, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2103588

RESUMO

A case of cutaneous sporotrichosis is reported for the first time in Thailand. The infection occurred in a 33-year-old Thai female who has been in good health and had no history of previous trauma or contact with any animals. Histopathology revealed pseudoepitheliomatous hyperplasia of the epidermis and a combination of granulomatous and pyogenic reactions in the dermis and subcutaneous tissue. Typical asteroid bodies (Splendore-Hoeppli phenomenon) with central yeast cells were seen. Sporothrix schenckii was recovered from skin biopsy specimens. The patient responded well to the treatment with saturated solutions of potassium iodide within three months. No recurrence was seen after more than six months follow-up.


Assuntos
Dermatomicoses , Sporothrix/crescimento & desenvolvimento , Esporotricose , Adulto , Dermatomicoses/tratamento farmacológico , Dermatomicoses/microbiologia , Dermatomicoses/patologia , Feminino , Humanos , Iodeto de Potássio/uso terapêutico , Esporotricose/tratamento farmacológico , Esporotricose/microbiologia , Esporotricose/patologia , Tailândia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...